Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134861) titled 'A study on the value of a gene marker in the diagnosis and prognosis of esophageal squamous cell carcinoma' on Oct. 21.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhoukou Central Hospital
Condition:
Patients with primary esophageal squamous cell carcinoma confirmed by pathology, including those with different TNM stages and clinicopathological features.
Intervention:
ESCC group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: ESCC group:100;Healthy control group:50;
Countries of Recruitment:
China
To know mor...